Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AbbVie files NDA with FDA for tavapadon to treat Parkinson’s disease
The NDA submission is based on findings from the TEMPO clinical development programme. Credit: National Institute of Allergy and Infectious Diseases on Unsplash.
The NDA submission is based on findings from the TEMPO clinical development programme. Credit: National Institute of Allergy and Infectious Diseases on Unsplash.